STAT+: At a flashy new research hub, AstraZeneca lays out ambitious growth goals
CAMBRIDGE, England — On a bit of a roll, AstraZeneca on Tuesday laid out ambitious…
Category: Medicine
.jpg)
Lilly doubles down on radiopharma
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: AltruBio raises $225 million to develop ulcerative colitis drug and other immune checkpoint enhancers
Checkpoint inhibitors, drugs that unleash the immune system, have turned into blockbuster therapies that have…
STAT+: GSK’s asthma push continues as drug succeeds in Phase 3 trials
A new asthma treatment that could be administered just once every six months has succeeded…
Opinion: As a primary care physician, here’s how I hope to partner with AI
I am both excited and terrified by the entrance of artificial intelligence into my primary…
Black Americans’ risk for breast cancer gains clarity in analysis of 40,000 genomes
Hundreds of genetic variants can nudge someone’s risk of breast cancer up or down or…
How doctors are pressuring sickle cell patients into unwanted sterilizations
BATON ROUGE, La. — The surgery was supposed to alleviate worry, but now, years later,…
Opinion: Reports of telehealth’s death have been greatly exaggerated
“Telehealth is collapsing.” “Telehealth is going through a contraction.” “There is a dark cloud hovering…
.jpg)
Move over, wastewater. Store-bought milk could be another way to track the bird flu outbreak in cows
Scientists from the University of Washington and the Fred Hutchinson Cancer Center have managed to…
STAT+: PBM executives invited to testify before House panel
WASHINGTON — Executives from the three major pharmacy benefit manager companies have been invited to…
STAT+: AI & drug discovery: A biotech CEO, a scientist, and a venture capitalist separate hype from reality
Artificial intelligence is a rapidly improving technology. But its progress in drug development faces an…
STAT+: BIO to announce reorganization, senior leaders expected to depart
WASHINGTON — The Biotechnology Innovation Organization on Monday is announcing a significant restructuring accompanied by…
STAT+: A novel spinal cord stimulator treats paralysis without surgery. FDA will rule on it soon
After his spinal cord injury in 2014, Sherown Campbell worked hard to regain as much…
STAT+: Class action against UnitedHealth asks about DOJ probe transparency
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: Pharmalittle: We’re reading about Sanders’ pharma pressure campaign, AstraZeneca’s new ADC factory, and more
Good morning from STAT reporter Andrew Joseph, filling in here for Mr. Pharmalot. We’ve recently…
STAT+: Private equity escapes FTC in court, but anesthesia group doesn’t
Welsh, Carson, Anderson & Stowe has wiggled out of the grasp of the Federal Trade…
STAT+: Medical crowdfunding isn’t a solution for skyrocketing health care costs
In the United States, health care costs are so out of control that medical crowdfunding…
STAT+: Bernie Sanders may have reached the limits of his pharma pressure campaign
WASHINGTON — Bernie Sanders is figuring out just how far bullying drugmakers can take him….
Opinion: HHS’s proposed rule pays lip service to addressing the climate crisis, the greatest threat to human health
In April, the U.S. Department of Health and Human Services, the world’s most powerful health…
STAT+: Why health systems are faring better so far in 2024
Americans, especially Medicare beneficiaries, are getting more medical care these days. Demand from aging Baby…
Opinion: Best time to deliver public health messages? When people are thinking about their health
I was 31 years old when my mother was dying of breast cancer. One day,…
Removing race adjustment from lung test could mean higher disability payments for Black vets
Removing a patient’s race from an equation used to assess lung function — a change…
Opinion: Readers respond to H5N1 and livestock movements, insulin discontinuation, and more
To encourage robust, good-faith discussion about difficult issues, STAT publishes selected Letters to the Editor…
Animal studies lend support to an innovative HIV vaccine strategy — but there’s still a long way to go
HIV has long stumped immunologists looking to develop an effective vaccine. All of the most…
Black women founders offer health tech solutions to combat Black maternal mortality
When Black people receive maternal care, they are often not treated the same as white…
STAT+: ChatGPT for genomes: introducing a CRISPR-designing generative AI
In 2018, during her chemistry Nobel Prize lecture, Frances Arnold noted that scientists had arrived…
STAT+: Venture capitalist Bob Kocher on generative AI startups, Change Healthcare cyberattack
SAN FRANCISCO — Health tech investor Bob Kocher has seen some bad AI-related startup pitches…
STAT+: Wearable devices generate powerful data but it’s not useful to doctors, yet
Just because the Food and Drug Administration has given the Apple Watch and other wearable…
STAT+: Amid acquisition speculation, Cytokinetics CEO stresses company can launch heart drug on its own
As Cytokinetics faces pressure to sell itself to a large pharma company following positive late-stage…
STAT+: Pharmalittle: We’re reading about an Amgen drug for lung cancer, a Novo plant fire, and more
And so, another working week will soon draw to a close. Not a moment too…
AstraZeneca antibody reduced Covid-19 risk in immunocompromised
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Hurricane season is approaching fast. We need to talk about health care resilience
Extreme weather fueled by accelerating climate change puts patients, providers, and health care facilities at…
Opinion: H5N1 doesn’t have to be a repeat of Covid-19’s ‘public health versus the economy’
The Biden administration announced new programs on May 10 to incentivize dairy farmers and workers…
STAT+: Data integrity watchdogs call for stronger safeguards in scientific journals
SAN FRANCISCO — According to Elisabeth Bik, a scientific watchdog who has discovered thousands of…
STAT+: To bolster global health, Wellcome Trust’s new CEO thinks Big Tech should get involved
LONDON — The key groups involved in addressing global health problems often include governments, foundations,…
Listen: Live! From the STAT Breakthrough Summit West
On this week’s “Readout LOUD,” we’re live in San Francisco at STAT’s Breakthrough Summit West….
Amid backlash to harm reduction, addiction experts warn against reprising ‘war on drugs’
SAN FRANCISCO — Amid what feels like an ever-worsening drug crisis here, locals and politicians…
STAT+: NVIDIA’s Kimberly Powell touts progress on AI in drug discovery
SAN FRANCISCO — In the world of drug discovery, AI progress is often measured by…
STAT+: Microsoft’s Peter Lee says ChatGPT shouldn’t be used for initial diagnosis
SAN FRANCISCO — Surging interest in generative AI among medical professionals since ChatGPT’s launch is…
Second House panel advances two-year telehealth extension
WASHINGTON — A House subcommittee on Thursday advanced legislation that would extend some pandemic-era telehealth…
In military medicine, study shows rank and race affect care
Higher ranking military officers receive more resources and better care than low ranking military officers,…
STAT+: Analysis of pharmaceutical R&D ranks Novo Nordisk and Johnson & Johnson above their peers
When it comes to bringing an experimental drug to market and selling it, Novo Nordisk,…
WuXi Biologics beefs up its lobbying operation
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: PDS Biotech’s survival benefit is absurdly overstated
This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers…
STAT+: Pharmalittle: We’re reading about a Roche obesity drug, an experimental Lilly insulin, and more
Top of the morning to you, and a fine one it is, despite the gray…
Opinion: As childhood asthma worsens, insurers restrict access to an essential medication
As pediatricians who take care of children in the inpatient, emergency, and primary care settings,…
STAT+: Biogen, Ionis drop ALS treatment after study failure
A plan to use new genetic techniques to treat non-genetic forms of ALS failed in…
Blackstone wants in on red-hot immunology market
The need-to-know this morning Biogen and Ionis Pharmaceuticals are ending their development of an experimental drug for ALS based on…
STAT+: Lilly’s weekly insulin works as well as daily products, new studies show
Eli Lilly reported Thursday that its experimental weekly insulin worked as well as daily basal…
STAT+: Obesity drug from Roche succeeds in early test, sending company shares up
LONDON — Roche on Thursday said its recently acquired experimental obesity medication helped people lose…